A subpopulation of CD56− CD16+ (V) cells was also identified, as shown in Figure 2(a); peripheral blood results for a single control and a single patient with ALL and bone marrow results for a single patient with ALL are displayed. Here, NCAM1 is linked to acute lymphoblastic leukemia.